Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Diet changes can help reduce acne by limiting certain hormones.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Modified stem cells from umbilical cord blood can make hair grow faster.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Flutamide, dutasteride, and finasteride dissolve differently in supercritical carbon dioxide, with dutasteride dissolving the least.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Animal models are crucial for learning about hair loss and finding treatments.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Birth control pills can help reduce mild to moderate acne in women.

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.